Risk Factors and Clinical Outcomes of Candidemia Associated With Severe COVID-19
IMPORTANCE:. COVID-19 can cause serious illness requiring multimodal treatment and is associated with secondary infections. Studies have suggested an increased risk of fungal infections, including candidemia following severe COVID-19 though understanding of risk factors and clinical outcomes remains...
Main Authors: | Deepali Dixit, PharmD, BCPS, BCCCP, FCCM, Polly Jen, PharmD, BCPS, BCIDP, AAHIVP, Tyler D. Maxwell, BS, PharmD, Steven Smoke, PharmD, BCPS, BCIDP, James Andrew McCracken, PharmD, Maria Cardinale-King, PharmD, BCCCP, Aditi Haribhakti, PharmD Candidate, Purvi Patel, MD, Eris Cani, BS, PharmD, BCIDP, BCPS, Seohyun (Claudia) Choi, PharmD, BCCCP, Sugeet Jagpal, MD, Tilly Varughese, MD, Luis L. Tatem, MD, Tanaya Bhowmick, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2022-09-01
|
Series: | Critical Care Explorations |
Online Access: | http://journals.lww.com/10.1097/CCE.0000000000000762 |
Similar Items
-
A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate versus Tenofovir Alafenamide
by: Chanie Wassner PharmD, BCCCP, BCIDP, et al.
Published: (2020-04-01) -
Evaluation of drug-drug interactions in hospitalized patients on medications for OUD
by: Olivia Berger, PharmD, et al.
Published: (2021-07-01) -
Multicenter Retrospective Review of Ketamine Use in the ICU
by: Christine M. Groth, PharmD, BCCCP, FCCM, et al.
Published: (2022-02-01) -
Optimizing Antiretroviral Therapy in Treatment-Experienced Patients Living with HIV: A Critical Review of Switch and Simplification Strategies. An Opinion of the HIV Practice and Research Network of the American College of Clinical Pharmacy
by: Daniel Chastain PharmD, BCIDP, AAHIVP, et al.
Published: (2019-09-01) -
Implementation and Impact of Critical Care Pharmacist Addition to a Telecritical Care Network
by: Rachel M. Belcher, PharmD, BCCCP, et al.
Published: (2023-01-01)